Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for VTRS, sign up here.
Income Statement
Revenue
$15.4bn
Gross Profit
$6.4bn
Earning before Tax
$202.9m
Net Income
$54.7m
Net Income Common Shareholders
$54.7m
EPS
0.05
Balance Sheet
Cash
$991.9m
Debt
$18.1bn
Assets
$47.7bn
Liabilities
$27.2bn
Equity
$20.5bn
Enterprise Value
$30.1bn
Cash Flow Statement
Net Cash from Operations
$2.8bn
Net Cash from Investing
$-0.8bn
Net Cash from Financing
$-2.3bn
Net Cash Flow
$-0.3bn
Free Cash Flow
$2.4bn
Free Cash Flow per Share
$2.03
Metrics
Price to Equity
0.0m
Price to Equity (Damodaran)
216.60
Price to Book
0.64
Net Margin
0.00
Return on Equity
0.00
Return on Sales
0.05
Get immediate access to 5-years of reference grade data for VTRS for free.
Sign upViatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Company Info
Industry
Drug Manufacturers - Specialty & Generic
Employees
38,000
Address
1000 Mylan Boulevard
Canonsburg, PA 15317
United States
Phone
724 514 1800
Website
Last Updated
2024-02-15
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.